Treatment of agitation in terminally ill patients with intranasal midazolam versus subcutaneous midazolam: study protocol for a randomised controlled open-label monocentric trial (MinTU Study)

Peer Review reports

Original Submission
25 Oct 2023	Submitted	Original manuscript
28 Nov 2023	Reviewed	Reviewer Report
28 Nov 2023	Reviewed	Reviewer Report
12 Dec 2023	Author responded	Author comments - Hanna Hirschinger
Resubmission - Version 2
12 Dec 2023	Submitted	Manuscript version 2
14 Dec 2023	Reviewed	Reviewer Report
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
14 Dec 2023	Editorially accepted
3 Jan 2024	Article published	10.1186/s12904-023-01330-1

Back to article page